-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Although specific DNA mutations can cause tumors, they do not promote transformation in all cellular contexts
Baggiolini et al.
Cells that are prone to tumor formation show higher levels of chromatin-modifying factors, such as ATAD2 protein
Structured abstract
Tumor analysis shows that DNA mutations can transform cells in some cases
principle
During development, neural crest cells produce melanocytes, which then further differentiate into melanocytes
result
We modified the zebrafish to use the sox10 promoter, mitfa promoter or tyrp1 promoter to drive the expression of BRAFV600E under the background of p53-/-
To extend these results to human cells, we developed a tumor model derived from human pluripotent stem cells (hPSC)
Performing RNA sequencing on these cells (with or without BRAFV600E), we found that neural crest cells and melanocytes have a strong transcriptional response to oncogenes, and although the activation of phosphorylated extracellular signal-regulated kinase (pERK) is the same, But melanocytes hardly changed
Pathway analysis showed that several chromatin-modifying enzymes, including readers, writers, and erasers (ATAD2, BPTF, BAZ1A, EZH2, etc.
In vitro, expression of ATAD2 in hPSC-derived melanocytes formed a phenotype more like progenitor cells, and inhibition of ATAD2 impaired neural crest differentiation
in conclusion
Overall, these data indicate that carcinogenicity is mediated by oncogenes (such as BRAFV600E), lineage-specific transcription factors (such as SOX10), and chromatin modifiers (such as ATAD2) that regulate development
###
Developmental chromatin programs determine oncogenic competence in melanoma
SCIENCE 3 Sep 2021 Vol 373, Issue 6559
DOI: 10.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.